208 related articles for article (PubMed ID: 17178441)
1. Use of quantitative real-time PCR to monitor the shedding and treatment of chlamydiae in the koala (Phascolarctos cinereus).
Markey B; Wan C; Hanger J; Phillips C; Timms P
Vet Microbiol; 2007 Mar; 120(3-4):334-42. PubMed ID: 17178441
[TBL] [Abstract][Full Text] [Related]
2. Using quantitative polymerase chain reaction to correlate Chlamydia pecorum infectious load with ocular, urinary and reproductive tract disease in the koala (Phascolarctos cinereus).
Wan C; Loader J; Hanger J; Beagley K; Timms P; Polkinghorne A
Aust Vet J; 2011 Oct; 89(10):409-12. PubMed ID: 21933169
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of chlamydial infection and disease in a free-ranging koala (Phascolarctos cinereus) population.
Nyari S; Waugh CA; Dong J; Quigley BL; Hanger J; Loader J; Polkinghorne A; Timms P
PLoS One; 2017; 12(12):e0190114. PubMed ID: 29281731
[TBL] [Abstract][Full Text] [Related]
4. Molecular evidence for novel chlamydial infections in the koala (Phascolarctos cinereus).
Devereaux LN; Polkinghorne A; Meijer A; Timms P
Syst Appl Microbiol; 2003 Jun; 26(2):245-53. PubMed ID: 12866851
[TBL] [Abstract][Full Text] [Related]
5. Chlamydia pecorum gastrointestinal tract infection associations with urogenital tract infections in the koala (Phascolarctos cinereus).
Phillips S; Robbins A; Loader J; Hanger J; Booth R; Jelocnik M; Polkinghorne A; Timms P
PLoS One; 2018; 13(11):e0206471. PubMed ID: 30383822
[TBL] [Abstract][Full Text] [Related]
6. Plasma concentrations of chloramphenicol after subcutaneous administration to koalas (Phascolarctos cinereus) with chlamydiosis.
Govendir M; Hanger J; Loader JJ; Kimble B; Griffith JE; Black LA; Krockenberger MB; Higgins DP
J Vet Pharmacol Ther; 2012 Apr; 35(2):147-54. PubMed ID: 21569052
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal study of wild koalas (Phascolarctos cinereus) reveals chlamydial disease progression in two thirds of infected animals.
Robbins A; Hanger J; Jelocnik M; Quigley BL; Timms P
Sci Rep; 2019 Sep; 9(1):13194. PubMed ID: 31519969
[TBL] [Abstract][Full Text] [Related]
8. Comparison of antigen detection and quantitative PCR in the detection of chlamydial infection in koalas (Phascolarctos cinereus).
Hanger J; Loader J; Wan C; Beagley KW; Timms P; Polkinghorne A
Vet J; 2013 Mar; 195(3):391-3. PubMed ID: 22944246
[TBL] [Abstract][Full Text] [Related]
9. Chlamydia pecorum prevalence in South Australian koala (Phascolarctos cinereus) populations: Identification and modelling of a population free from infection.
Fabijan J; Caraguel C; Jelocnik M; Polkinghorne A; Boardman WSJ; Nishimoto E; Johnsson G; Molsher R; Woolford L; Timms P; Simmons G; Hemmatzadeh F; Trott DJ; Speight N
Sci Rep; 2019 Apr; 9(1):6261. PubMed ID: 31000763
[TBL] [Abstract][Full Text] [Related]
10. Molecular evidence for chlamydial infections in the eyes of sheep.
Polkinghorne A; Borel N; Becker A; Lu ZH; Zimmermann DR; Brugnera E; Pospischil A; Vaughan L
Vet Microbiol; 2009 Mar; 135(1-2):142-6. PubMed ID: 18945556
[TBL] [Abstract][Full Text] [Related]
11. Microbiota composition of the koala (Phascolarctos cinereus) ocular and urogenital sites, and their association with Chlamydia infection and disease.
Vidgen ME; Hanger J; Timms P
Sci Rep; 2017 Jul; 7(1):5239. PubMed ID: 28701755
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in understanding the biology, epidemiology and control of chlamydial infections in koalas.
Polkinghorne A; Hanger J; Timms P
Vet Microbiol; 2013 Aug; 165(3-4):214-23. PubMed ID: 23523170
[TBL] [Abstract][Full Text] [Related]
13. Variation in the microbiome of the urogenital tract of Chlamydia-free female koalas (Phascolarctos cinereus) with and without 'wet bottom'.
Legione AR; Amery-Gale J; Lynch M; Haynes L; Gilkerson JR; Sansom FM; Devlin JM
PLoS One; 2018; 13(3):e0194881. PubMed ID: 29579080
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 17A is an immune marker for chlamydial disease severity and pathogenesis in the koala (Phascolarctos cinereus).
Mathew M; Waugh C; Beagley KW; Timms P; Polkinghorne A
Dev Comp Immunol; 2014 Oct; 46(2):423-9. PubMed ID: 24915607
[TBL] [Abstract][Full Text] [Related]
15. Chlamydiaceae and Chlamydia-like organisms in the koala (Phascolarctos cinereus)--organ distribution and histopathological findings.
Burach F; Pospischil A; Hanger J; Loader J; Pillonel T; Greub G; Borel N
Vet Microbiol; 2014 Aug; 172(1-2):230-40. PubMed ID: 24888862
[TBL] [Abstract][Full Text] [Related]
16. Clinical comparison of five anti-chlamydial antibiotics in koalas (Phascolarctos cinereus).
Booth R; Nyari S
PLoS One; 2020; 15(7):e0236758. PubMed ID: 32730301
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Chlamydia-associated ocular disease via a recombinant protein based vaccine in the koala (Phascolarctos cinereus).
Waugh C; Austin R; Polkinghorne A; Timms P
Biologicals; 2016 Nov; 44(6):588-590. PubMed ID: 27707559
[TBL] [Abstract][Full Text] [Related]
18. PREVALENCE AND PATHOLOGIC FEATURES OF CHLAMYDIA PECORUM INFECTIONS IN SOUTH AUSTRALIAN KOALAS (PHASCOLARCTOS CINEREUS).
Speight KN; Polkinghorne A; Penn R; Boardman W; Timms P; Fraser T; Johnson K; Faull R; Bate S; Woolford L
J Wildl Dis; 2016 Apr; 52(2):301-6. PubMed ID: 26967132
[TBL] [Abstract][Full Text] [Related]
19. The prevalence and clinical significance of Chlamydia infection in island and mainland populations of Victorian koalas (Phascolarctos cinereus).
Patterson JL; Lynch M; Anderson GA; Noormohammadi AH; Legione A; Gilkerson JR; Devlin JM
J Wildl Dis; 2015 Apr; 51(2):309-17. PubMed ID: 25588005
[TBL] [Abstract][Full Text] [Related]
20. Optimising the short and long-term clinical outcomes for koalas (Phascolarctos cinereus) during treatment for chlamydial infection and disease.
Robbins A; Loader J; Timms P; Hanger J
PLoS One; 2018; 13(12):e0209679. PubMed ID: 30589897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
